Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05306977 · ClinicalTrials.gov registry record · NA
rTMS Pilot for Anxiety
A NA study, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT05306977: Clinical Trial NA study, sponsored by University of Pennsylvania.
NCT05306977 is a NA study that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05306977, a NA study, was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and tolerability of 1 Hz parietal stimulation in anxiety. Our approach will be to administer 1 week of open-label accelerated 1 Hz parietal rTMS (5 days, 8 sessions/day, 600 pulses/session) and measure the effect of this neuromodulation on APS, and short term memory in a cohort of anxiety GAD patients.
Interventions
- DEVICE Open-label accelerated 1 Hz repetitive transcranial magnetic stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2022-05-19 |
| Est. Completion | 2022-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05306977
The ClinicalTrials.gov registry entry for NCT05306977 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Open-label accelerated 1 Hz repetitive transcranial magnetic stimulation is the first listed.
NCT05306977 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05306977 about?
NCT05306977 is a clinical study titled "rTMS Pilot for Anxiety". The purpose of this study is to evaluate the safety and tolerability of 1 Hz parietal stimulation in anxiety. Our approach will be to administer 1 week of open-label accelerated 1 Hz parietal rTMS (5 days, 8 sessions/day, 600 pulses/session) and measure the effect of this neuromodulation on APS, and...
What is the current status of trial NCT05306977?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2022-05-19. Estimated completion is 2022-08-01.
What interventions are being tested in trial NCT05306977?
The interventions under investigation include: Open-label accelerated 1 Hz repetitive transcranial magnetic stimulation (DEVICE).
Who is sponsoring clinical trial NCT05306977?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.